ID24306A - Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori - Google Patents

Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori

Info

Publication number
ID24306A
ID24306A IDW991108A ID991108A ID24306A ID 24306 A ID24306 A ID 24306A ID W991108 A IDW991108 A ID W991108A ID 991108 A ID991108 A ID 991108A ID 24306 A ID24306 A ID 24306A
Authority
ID
Indonesia
Prior art keywords
kuinolin
carcoxicate
amito
antagonists
acid decrease
Prior art date
Application number
IDW991108A
Other languages
English (en)
Inventor
Giuseppe Alvaro
Barbara Bertani
Romano Di Fabio
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of ID24306A publication Critical patent/ID24306A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
IDW991108A 1997-03-26 1998-03-24 Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori ID24306A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706294.7A GB9706294D0 (en) 1997-03-26 1997-03-26 Heterocyclic compound

Publications (1)

Publication Number Publication Date
ID24306A true ID24306A (id) 2000-07-13

Family

ID=10809909

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991108A ID24306A (id) 1997-03-26 1998-03-24 Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori

Country Status (20)

Country Link
EP (1) EP0971896A1 (id)
JP (1) JP2001518901A (id)
KR (1) KR20010005567A (id)
CN (1) CN1257482A (id)
AP (1) AP9901659A0 (id)
AU (1) AU731394B2 (id)
BR (1) BR9808424A (id)
CA (1) CA2284710A1 (id)
EA (1) EA199900755A1 (id)
GB (1) GB9706294D0 (id)
HU (1) HUP0001661A3 (id)
ID (1) ID24306A (id)
IL (1) IL131919A0 (id)
IS (1) IS5186A (id)
NO (1) NO994679L (id)
NZ (1) NZ337793A (id)
PL (1) PL335865A1 (id)
TR (1) TR199902315T2 (id)
WO (1) WO1998042673A1 (id)
YU (1) YU47699A (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
DE10132725A1 (de) 2001-07-05 2006-08-03 Grünenthal GmbH Substituierte γ-Lactonverbindungen
DE10137487A1 (de) * 2001-08-03 2003-03-27 Gruenenthal Gmbh Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
JP4360891B2 (ja) 2003-12-09 2009-11-11 アルパイン株式会社 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法
KR101136183B1 (ko) 2005-07-22 2012-04-17 모찌다 세이야쿠 가부시끼가이샤 신규 헤테로시클리덴 아세트아미드 유도체
RU2451014C2 (ru) * 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
JP7305560B2 (ja) 2017-06-12 2023-07-10 グリテック, エルエルシー Nmdaアンタゴニスト及びd2/5ht2a又は選択的5ht2aアンタゴニストによるうつ病の治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386839B1 (en) * 1989-03-08 1997-01-15 Merck Sharp & Dohme Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
TR199800531T1 (xx) * 1995-09-29 1998-06-22 Glaxo Wellcome Spa NMDA antagonistleri olarak tetrahidrokinolinler.
GB9617305D0 (en) * 1996-08-17 1996-09-25 Glaxo Wellcome Spa Heterocyclic compounds

Also Published As

Publication number Publication date
GB9706294D0 (en) 1997-05-14
PL335865A1 (en) 2000-05-22
TR199902315T2 (xx) 2000-05-22
AP9901659A0 (en) 1999-09-30
HUP0001661A3 (en) 2001-12-28
NZ337793A (en) 2001-02-23
JP2001518901A (ja) 2001-10-16
NO994679L (no) 1999-11-24
WO1998042673A1 (en) 1998-10-01
IL131919A0 (en) 2001-03-19
AU7209498A (en) 1998-10-20
CN1257482A (zh) 2000-06-21
AU731394B2 (en) 2001-03-29
EP0971896A1 (en) 2000-01-19
KR20010005567A (ko) 2001-01-15
BR9808424A (pt) 2000-05-23
EA199900755A1 (ru) 2000-08-28
NO994679D0 (no) 1999-09-24
HUP0001661A2 (hu) 2000-09-28
YU47699A (sh) 2001-12-26
CA2284710A1 (en) 1998-10-01
IS5186A (is) 1999-09-17

Similar Documents

Publication Publication Date Title
ID26099A (id) Turunan amida dan antagonis nosiseptin
HK1030768A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents.
ID23953A (id) Asam 5-alkil-2-arilaminofenilasetat dan turunannya
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID19586A (id) Komposisi-komposisi gelas silika-soda-kapur dan pemakaiannya
ID24475A (id) Turunan-turunan amina siklik dan penggunaannya sebagai obat
ID21361A (id) Baterai dan metode pembuatannya
ID25591A (id) Senyawa-senyawa asam meta-azasiklik amino benzoat dan turunan-turunannya yang merupakan antagonis integrin
ID24686A (id) Enzim-enzim biosintetik asam amino tanaman
ID22873A (id) Senyawa-senyawa heterosiklik dan pemakaiannya untuk menginhibisi b-amyloid peptida
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID24196A (id) Komposisi dan penggunaan
ID22916A (id) Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin
NO993901D0 (no) Bisykliske aminosyrer
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
HUP0003484A3 (en) Pyrrolidine-3-crboxylic acid derivatives and their use as endothelin antagonists
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
ID24306A (id) Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori
DE69513832D1 (de) Exzitatorische aminosäure-rezeptor-antagonisten
ID24810A (id) Turunan-turunan isoquinolin tersubstitusi dan penggunaannya sebagai anti-kejang
ID26234A (id) Turunan-turunan asam karboksilat heterosiklik, pembuatan dan penggunaannya sebagai antagonis-antagonis reseptor endotelen
DE69801856D1 (de) Befestigungselement
ID25857A (id) Komposisi farmasi
ID24346A (id) Turunan asam karboksilat betha -amino dan betha -azido baru, pembuatan dan penggunaannya sebagai antagonis reseptor andotelin